Trial intelligence / Profile preview

Efficacy of OsteoBor in Postmenopausal Osteoporosis

IRCT20220614055167N6Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of OsteoBor in osteoporosis, sponsored by Tabriz University of Medical Sciences. Started Mar 2025; status: completed.

02

Drugs

OsteoBor
03

Conditions

osteoporosis

Beyond the preview

Go deeper on IRCT20220614055167N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220614055167N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call